Top compounds associated with response to CTNND2


Feature Type Standardized
Nominal ANOVA
mRNA GSK2126458 GDSC1000 pan-cancer AAC 0.014 0.7
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC -0.02 0.7
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA istradefylline CTRPv2 pan-cancer AAC 0.024 0.7
mRNA T0901317 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.7
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.015 0.7
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA RAF265 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA nelarabine CTRPv2 pan-cancer AAC 0.016 0.7
Download CSV